Trifecta Capital Advisors
CVS icon

Trifecta Capital Advisors’s CVS Health CVS Stock Holding History

Trifecta Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-18
Closed -$1.86K – 353
2026
Q2 		$1.86K Buy
+18
New +$1.61K ﹤0.01% 310
2024
Q2 		– Sell
-1,500
Closed -$120K – 422
2024
Q1 		$120K Sell
1,500
-11
-0.7% -$840 0.03% 104
2023
Q4 		$119K Sell
1,511
-57
-4% -$4.06K 0.03% 98
2023
Q3 		$109K Buy
1,568
+25
+2% +$1.77K 0.04% 99
2023
Q2 		$107K Buy
1,543
+11
+0.7% +$783 0.03% 105
2023
Q1 		$114K Buy
1,532
+1,500
+4,688% +$126K 0.04% 104
2022
Q4 		$2.98K Buy
+32
New +$3.09K ﹤0.01% 259

Other funds holding CVS

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Davis Selected Advisers
Davis Selected Advisers Tucson, Arizona $23.2B AUM 18.42% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Trifecta Capital Advisors's CVS Position: Q3 2026 in Review

Trifecta Capital Advisors sold out of CVS Health (CVS) in Q3 2026, closing a stake of 18 shares — an estimated $1.86K sold.

Trifecta Capital Advisors first reported a position in CVS in Q4 2022 and held it in 7 quarters. The position peaked at $120K in Q1 2024. 1,515 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Trifecta Capital Advisors reported no remaining CVS Health position as of Q3 2026 after selling out during the quarter.
  • Trifecta Capital Advisors sold 18 CVS Health shares in Q3 2026, an estimated $1.86K.
  • Trifecta Capital Advisors first reported a position in CVS Health in Q4 2022 and held it in 7 quarters.
  • Trifecta Capital Advisors's CVS Health position peaked at $120K in Q1 2024.
  • 1,515 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Trifecta Capital Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.